Recording of ’COVID-19 vaccine declined‘: a cohort study on 57.9 million National Health Service patients’ records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021
Journal article
Curtis HJ. et al, (2022), Eurosurveillance, 27
Software development skills for health data researchers
Journal article
Morton C. et al, (2022), BMJ Health and Care Informatics, 29
Comparative effectiveness of BNT162b2 versus mRNA-1273 boosting in England: a cohort study in OpenSAFELY-TPP
Preprint
Hulme W. et al, (2022)
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform
Journal article
Walker JL. et al, (2022), Vaccine, 40, 4479 - 4487
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.
Journal article
Hulme WJ. et al, (2022), BMJ, 378
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
Journal article
Horne EMF. et al, (2022), BMJ (Clinical research ed.), 378
Association between oral anticoagulants and COVID-19-related outcomes: a population-based cohort study
Journal article
Wong AYS. et al, (2022), British Journal of General Practice, 72, E456 - E463
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records
Journal article
Thygesen JH. et al, (2022), The Lancet Digital Health, 4, e542 - e557
Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people
Journal article
Shah SA. et al, (2022), eClinicalMedicine, 49
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
Journal article
MacKenna B. et al, (2022), The Lancet Rheumatology, 4, e490 - e506
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England
Journal article
Grint DJ. et al, (2022), Clinical Infectious Diseases, 75, E1120 - E1127
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study
Preprint
The OpenSAFELY Collaborative None. et al, (2022)
Trends and variation in data quality and availability on the European Union Clinical Trials Register: A cross-sectional study
Journal article
DeVito NJ. and Goldacre B., (2022), Clinical Trials, 19, 172 - 183
Trends, variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY
Preprint
The OpenSAFELY Collaborative None. et al, (2022)
Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65
Journal article
Schultze A. et al, (2022), The Lancet Regional Health - Europe, 14
Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY
Journal article
Fisher L. et al, (2022), Thrombosis Research, 211, 150 - 153